← Back to Search

Community Intervention for Adolescent Violence (SOAR Trial)

N/A
Waitlist Available
Research Sponsored by University of South Alabama
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up trajectories of change will be assessed through data collected every three months from august to may (the school year) over the course of five years (through study completion)
Awards & highlights

SOAR Trial Summary

This trial seeks to reduce violence and suicide in African American youth by addressing inequity in education & law enforcement. It has potential to improve quality of life & reduce societal costs.

Who is the study for?
This trial is for African American youth attending participating schools, school personnel employed at these schools, and police from participating precincts. Participants must understand English and be able to give assent or consent.Check my eligibility
What is being tested?
The study tests a multisystemic prevention program aimed at reducing violence and suicide among African American youth by promoting equity in education and law enforcement systems.See study design
What are the potential side effects?
Since this is a community-level intervention focusing on systemic changes rather than medical treatments, it does not have traditional side effects like drugs do.

SOAR Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~trajectories of change will be assessed through data collected every three months from august to may (the school year) over the course of five years (through study completion)
This trial's timeline: 3 weeks for screening, Varies for treatment, and trajectories of change will be assessed through data collected every three months from august to may (the school year) over the course of five years (through study completion) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in base rates in exclusionary discipline
Change in inclusive pedagogy
Change in racial disparities in exclusionary discipline
+12 more
Secondary outcome measures
Change in youth self-reported depressive symptoms
Change in youth self-reported general internalizing symptoms
Change in youth self-reported traumatic stress symptoms

SOAR Trial Design

1Treatment groups
Experimental Treatment
Group I: Strengthening Opportunities for Achievement and ResilienceExperimental Treatment2 Interventions
Strengthening Opportunities for Achievement and Resilience (SOAR) is an intervention condition consisting of both Culturally-Responsive Schoolwide Positive Behavior Interventions and Supports (C-SWPBS) and Culturally Responsive Practices (CRP). It is a year-long, school-level intervention.

Find a Location

Who is running the clinical trial?

University of South AlabamaLead Sponsor
42 Previous Clinical Trials
14,262 Total Patients Enrolled
National Institute on Minority Health and Health Disparities (NIMHD)NIH
381 Previous Clinical Trials
1,214,384 Total Patients Enrolled
National Institutes of Health (NIH)NIH
2,696 Previous Clinical Trials
6,950,907 Total Patients Enrolled
8 Trials studying Suicide
19,835 Patients Enrolled for Suicide

Media Library

Integrated Community-Level Intervention Clinical Trial Eligibility Overview. Trial Name: NCT05639426 — N/A
Suicide Research Study Groups: Strengthening Opportunities for Achievement and Resilience
Suicide Clinical Trial 2023: Integrated Community-Level Intervention Highlights & Side Effects. Trial Name: NCT05639426 — N/A
Integrated Community-Level Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05639426 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

To what extent is the current clinical trial being administered to participants?

"Indeed, information pertaining to this clinical trial is available on the clinicaltrials.gov website and indicates that it has been active since October 10th 2022. The study requires 1952 participants from a single medical centre for its completion with updates being made as recently as November 25th 2022."

Answered by AI

Are participants being currently accepted for this experiment?

"Affirmative, according to clinicaltrials.gov, this medical trial is accepting new patients. Initially posted on October 10th 2022 and revised recently in November 25th 2022, the study aims to recruit 1952 individuals from one location."

Answered by AI
~1061 spots leftby Jan 2027